These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8779117)

  • 21. Long-lived picture priming in normal elderly persons and demented patients.
    Beatty WW; English S; Winn P
    J Int Neuropsychol Soc; 1998 Jul; 4(4):336-41. PubMed ID: 9656607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences between Alzheimer's disease and vascular dementia on information processing measures.
    Mendez MF; Cherrier MM; Perryman KM
    Brain Cogn; 1997 Jul; 34(2):301-10. PubMed ID: 9220093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium channel blockers and stroke.
    Inzitari D; Poggesi A
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits.
    Galgani S; Balestra P; Narciso P; Tozzi V; Sette P; Pau F; Visco G
    AIDS; 1997 Oct; 11(12):1520-1. PubMed ID: 9342076
    [No Abstract]   [Full Text] [Related]  

  • 25. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.
    Doddy RS; Massman PJ; Mawad M; Nance M
    Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):191-9. PubMed ID: 9845410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galantamine: use in Alzheimer's disease and related disorders.
    Bullock R
    Expert Rev Neurother; 2004 Mar; 4(2):153-63. PubMed ID: 15853556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types.
    Caputo M; Monastero R; Mariani E; Santucci A; Mangialasche F; Camarda R; Senin U; Mecocci P
    Acta Psychiatr Scand; 2008 Jun; 117(6):455-64. PubMed ID: 18363771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study of the tolerability and effectiveness of nicardipine retard in cognitive deterioration of vascular origin].
    González-González JA; Lozano R
    Rev Neurol; 2000 Apr 16-30; 30(8):719-28. PubMed ID: 10893735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia.
    Moretti R; Torre P; Antonello RM; Cazzato G; Pizzolato G
    Am J Alzheimers Dis Other Demen; 2008; 23(2):167-76. PubMed ID: 18184948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage-independent and stage-specific phenotypic differences between vascular dementia and Alzheimer's Disease.
    Chan M; Lim WS; Sahadevan S
    Dement Geriatr Cogn Disord; 2008; 26(6):513-21. PubMed ID: 19052451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
    Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ
    Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment.
    Lindeboom J; Weinstein H
    Eur J Pharmacol; 2004 Apr; 490(1-3):83-6. PubMed ID: 15094075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
    Ihl R
    MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nimodipine: test your drug IQ.
    Devlin MM
    Nursing; 2008 Jul; 38(7):56cc1-2. PubMed ID: 18580671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive differential diagnosis of dementing diseases: Alzheimer's Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive Disorder.
    Braaten AJ; Parsons TD; McCue R; Sellers A; Burns WJ
    Int J Neurosci; 2006 Nov; 116(11):1271-93. PubMed ID: 17000529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Brain aging and calcium antagonist drugs. A preliminary open study with nimodipine].
    Centonze V; Massaro C; Polito BM; Cassiano MA; Di Bari M; Russo P; Cirillo L; Albano O
    Clin Ter; 1992 Jan; 140(1):11-5. PubMed ID: 1526092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Calcium channel blockers in therapy of neurologic diseases].
    Wessely P; Wöber-Bingöl C
    Wien Med Wochenschr; 1993; 143(19-20):514-8. PubMed ID: 8135034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.